Retraction Note: The LINC00623/NAT10 signaling axis promotes pancreatic cancer progression by remodeling ac4C modification of mRNA

Zengyu Feng; Kexian Li; Kai Qin; Juyong Liang; Minmin Shi; Yang Ma; Shiwei Zhao; Huaiyu Liang; Dongni Han; Baiyong Shen; Chenghong Peng; Hao Chen; Lingxi Jiang

doi:10.1186/s13045-023-01506-5

Retraction Note: The LINC00623/NAT10 signaling axis promotes pancreatic cancer progression by remodeling ac4C modification of mRNA

J Hematol Oncol. 2023 Nov 1;16(1):109. doi: 10.1186/s13045-023-01506-5.

Authors

Zengyu Feng^#^{1

2}, Kexian Li^#¹, Kai Qin^#¹, Juyong Liang^#^{3

4}, Minmin Shi¹, Yang Ma¹, Shiwei Zhao¹, Huaiyu Liang⁵, Dongni Han⁶, Baiyong Shen^{1

7

8}, Chenghong Peng^{9

10}, Hao Chen^{11

12}, Lingxi Jiang^{13

14}

Affiliations

¹ Department of General Surgery, Pancreatic Disease Center, Research Institute of Pancreatic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, People's Republic of China.
² Department of General Surgery, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, People's Republic of China.
³ Otolaryngology and Head and Neck Center, Cancer Center, Department of Head and Neck Surgery, Zhejiang Provincial People'S Hospital (Affiliated People's Hospital, Hangzhou Medical College), Hangzhou, Zhejiang, People's Republic of China.
⁴ Key Laboratory of Endocrine Gland Diseases of Zhejiang Province, Hangzhou, Zhejiang, People's Republic of China.
⁵ Department of Pathology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.
⁶ State Key Laboratory of Analytical Chemistry for Life Science, School of Chemistry and Chemical Engineering, Nanjing University, Nanjing, People's Republic of China.
⁷ Shanghai Key Laboratory of Translational Research for Pancreatic Neoplasms, Shanghai, People's Republic of China.
⁸ Institute of Translational Medicine, Shanghai Jiao Tong University, Shanghai, People's Republic of China.
⁹ Department of General Surgery, Pancreatic Disease Center, Research Institute of Pancreatic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, People's Republic of China. chhpeng@yeah.net.
¹⁰ Shanghai Key Laboratory of Translational Research for Pancreatic Neoplasms, Shanghai, People's Republic of China. chhpeng@yeah.net.
¹¹ Department of General Surgery, Pancreatic Disease Center, Research Institute of Pancreatic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, People's Republic of China. haochendr@126.com.
¹² Shanghai Key Laboratory of Translational Research for Pancreatic Neoplasms, Shanghai, People's Republic of China. haochendr@126.com.
¹³ Department of General Surgery, Pancreatic Disease Center, Research Institute of Pancreatic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, People's Republic of China. jlx12120@rjh.com.cn.
¹⁴ Shanghai Key Laboratory of Translational Research for Pancreatic Neoplasms, Shanghai, People's Republic of China. jlx12120@rjh.com.cn.

^# Contributed equally.

No abstract available

Publication types

Retraction of Publication